66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Friendship Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
7. - 10. Juni 2015, Karlsruhe
Postersitzungen
P III Freie Themen II: Gliome experimentell
Meeting Abstract
(P 031)
[Volltext]
Element distribution analysis of glioma tissue and cells by using x-ray microscopy
Sachkova A, Ducic T, Sperling S, Grolimund D, Rohde V, Ninkovic M[Volltext]
Meeting Abstract
(P 032)
[Volltext]
CD133 expression is not synonymous with immunoreactivity for the diagnostic antibody AC133 and fluctuates throughout the cell cycle in glioma stem-like cells
Renovanz M, Barrantes-Freer A, Pardo L, Giese A, Kim EL[Volltext]
Meeting Abstract
(P 033)
[Volltext]
Expression of plasmolipin on glioma stem-like cells confers susceptibility to gene transduction using lentiviral McERV pseudotypes
Kim E, Renovanz M, Viehweg S, Giese A, Stocking C, Prassolov V[Volltext]
Meeting Abstract
(P 034)
[Volltext]
Role of co-chaperone BAG-1 in glioma
Müther M, Dohm C, Rave-Fränk M, Bähr M, Kermer P[Volltext]
Meeting Abstract
(P 035)
[Volltext]
E-cadherin propeptide modification potentially determines migratory and invasive behavior of glioma cells
Ritter S, Schackert G, Temme HA[Volltext]
Meeting Abstract
(P 036)
[Volltext]
Increased KIR4.1 immunoreactivity in human glioma tissue
Schirmer L, Ringel F, Butenschön VM, Srivastava R, Hemmer B, Gempt J[Volltext]
Meeting Abstract
(P 037)
[Volltext]
Alteration of FGF isoform expression in glioma patients of different WHO grades
Dreher L, Goldbrunner R, Timmer M[Volltext]
Meeting Abstract
(P 038)
[Volltext]
Differences in the expression of CD184, CD95, CD178 and CD40 in human gliomas of various grades, before and after chemotherapy
Werner J, Röhn G, Goldbrunner R, Timmer M[Volltext]
Meeting Abstract
(P 039)
[Volltext]
Anaplastic meningiomas WHO grade III lack of somatic AKT1-mutations and show an overexpression of EGF receptors
Juratli TA, Wiedemuth R, Geiger KD, Temme A, Kirsch M, Schackert G[Volltext]
Meeting Abstract
(P 040)
[Volltext]
A quantitative real-time PCR high resolution melting (HRM) method for evaluating the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in malignant gliomas is superior to conventional methylation specific PCR in predicting clinical outcome and survival in patients with malignant glioma
Switzeny OJ, Renovanz M, Sommer C, Christmann M, Giese A, Kaina B[Volltext]
Meeting Abstract
(P 041)
[Volltext]
No glow in the dark – why some gliomas are non-fluorescent: Histopathologic analysis of 140 high-grade gliomas
Hickmann AK, Nadji-Ohl M, Ganslandt O[Volltext]
Meeting Abstract
(P 042)
[Volltext]
Enhancement of the temozolomide effect with atorvastatin and pioglitazone on malignant glioma
Yildiz ÖC, Pérez JHT, Kirches E, Mawrin C, Schneider T[Volltext]
Meeting Abstract
(P 043)
[Volltext]
Overexpression of BIRC5/Survivin in glioma cells induces resistance against temozolomide and enhances tumorigenicity
Conde M, Düring I, Wiedemuth R, Schackert G, Temme A[Volltext]
